Standout Papers

Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations 2024 202637
  1. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations (2024)
    Aeron Small, Giorgio Melloni et al. JAMA Cardiology

Immediate Impact

39 standout
Sub-graph 1 of 19

Citing Papers

Apolipoprotein B-containing lipoproteins in atherogenesis
2025 Standout
Gut microbiota‐derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation
2025 Standout
1 intermediate paper

Works of Aeron Small being referenced

Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association
2024
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations
2024 Standout

Author Peers

Author Last Decade Papers Cites
Aeron Small 109 86 35 85 23 340
Sanne Bøjet Larsen 171 90 30 53 24 370
Gonzalo Aldámiz‐Echevarría 139 51 25 93 37 374
Marie Guerraty 203 56 28 82 25 329
Meng Jin 60 148 52 70 28 354
Sanne L. N. Brouns 98 53 15 95 21 389
Masahiko Shinohara 118 146 29 136 18 405
Takashi Iwakiri 81 68 18 88 19 394
Paul Sandhu 92 62 7 82 24 307
Tomokazu Ikemoto 112 41 54 113 22 311
Vanessa Arrieta 166 76 14 104 19 358

All Works

Loading papers...

Rankless by CCL
2026